European companies are enduring U.S. import tariffs, with Q2 earnings up 3.1% from last year. Financials and healthcare see the strongest growth. Banks beat expectations, fueling a sector surge. Healthcare grows 15%, but caution remains due to potential U.S. pharmaceutical levies. Consumer stocks struggle with tariffs and weak demand, leading to price hikes and strategy adjustments.

Read more at Yahoo Finance: Strong euro, tariff worries weigh but banks shine